<https://rdf.molmedb.upol.cz/reference/ref4209> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM00585>,
		<https://identifiers.org/molmedb/MM494616>,
		<https://identifiers.org/molmedb/MM495142>;
	<http://purl.org/ontology/bibo/doi> "10.1021/acs.jmedchem.0c02009"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/bibliographicCitation> "Vanda D, Canale V, Chaumont-Dubel S, Kurczab R, Satała G, Koczurkiewicz-Adamczyk P, Krawczyk M, Pietruś W, Blicharz K, Pękala E, Bojarski AJ, Popik P, Marin P, Soural M, Zajdel P.: Imidazopyridine-Based 5-HT<sub>6</sub> Receptor Neutral Antagonists: Impact of <i>N</i><sup>1</sup>-Benzyl and <i>N</i><sup>1</sup>-Phenylsulfonyl Fragments on Different Receptor Conformational States. J Med Chem, Volume 64 (2), 2021"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method30>,
		<https://rdf.molmedb.upol.cz/interaction/membrane18>;
	<http://purl.org/ontology/bibo/pmid> "33439019"^^<http://www.w3.org/2001/XMLSchema#string> .
<https://rdf.molmedb.upol.cz/interaction/int1021806> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4209> .
<https://rdf.molmedb.upol.cz/interaction/int1021449> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4209> .
<https://rdf.molmedb.upol.cz/interaction/int1020341> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref4209> .
